Omega Funds founder and managing director Otello Stampacchia isn’t afraid to tell it like he sees it.

Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Philanthropies, especially from venture-minded or justice-driven donors, could step in where policy has stalled. By funding ...

The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

With these trends in view, let’s look at the 10 best mid cap biotech stocks to buy.

The biotech, which has raised more than $140 million over several investment rounds in the last few years from the likes of ...

Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine ...

Bo Wang is a renowned AI scientist at the University of Toronto. He’s bringing his open-source culture and computational ...

Avance Clinical CEO Yvonne Lungershausen emphasized the importance of these new partnerships and highlighted the value of ...